Keyphrases
Therapeutic Approaches
100%
Glioma Cells
100%
Cell Survival
100%
AKT1
100%
SPARC
100%
Heat Shock Protein 27 (HSP27)
100%
Tumor Cell Survival
46%
Temozolomide
26%
Therapeutic Target
20%
Glioma
13%
Tumor Cells
13%
Apoptotic Pathway
13%
Treatment Regimen
13%
Cell Invasion
13%
Cancer Types
6%
Signaling Pathway
6%
Overall Survival
6%
Tumor
6%
Feedback System
6%
Therapeutic Agents
6%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
6%
Radiation Therapy
6%
Aggressive Treatment
6%
Current Treatment
6%
Pro-survival
6%
Chemosensitization
6%
Protein Signaling
6%
MAPKAPK2
6%
Glioma Patients
6%
Adjuvant Temozolomide
6%
Complex Feedback
6%
Dual Inhibition
6%
Surgically Treated
6%
PTEN-null
6%
Medicine and Dentistry
Glioma Cell
100%
Cell Survival
100%
Osteonectin
100%
Heat Shock Protein 27
100%
Tumor Cell
60%
Temozolomide
33%
Ganglioglioma
20%
Cell Invasion
13%
Neoplasm
6%
Upregulation
6%
Overall Survival
6%
Therapeutic Agent
6%
Radiation Therapy
6%
Cancer Types
6%
Signaling Protein
6%
p38 Mitogen-Activated Protein Kinase
6%
Chemosensitization
6%
Signal Transduction
6%
Immunology and Microbiology
Cell Survival
100%
Glioma Cell
100%
Tumor Cell
90%
Cell Invasion
20%
Upregulation
10%
Overall Survival
10%
Chemosensitization
10%
Signal Transduction
10%
Pharmacology, Toxicology and Pharmaceutical Science
Heat Shock Protein 27
100%
Osteonectin
100%
Neoplasm
66%
Temozolomide
33%
Malignant Neoplasm
6%
Overall Survival
6%
Biochemistry, Genetics and Molecular Biology
Cell Survival
100%
Osteonectin
100%
Cell Invasion
13%
AKT1
13%
Signal Transduction
6%
Signaling Protein
6%
P38 Mitogen-Activated Protein Kinases
6%
Upregulation
6%
Overall Survival
6%
Chemosensitization
6%
MAPKAPK2
6%